Trial Profile

Pilot Study of Unrelated Cord Blood Transplantation in Patients With Poor Risk Haematological Malignancies.

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Antithymocyte globulin; Busulfan; Ciclosporin; Cyclophosphamide; Fludarabine; Melphalan; Mycophenolate mofetil; Thiotepa
Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Graft-versus-host disease; Haematological malignancies; Hodgkin's disease; Leukaemia; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
Focus Adverse reactions

Most Recent Events

11 Feb 2015 Biomarkers information updated
28 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
28 Mar 2012 Actual initiation date (29 Feb 2008) added as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com